Vanguard Global Advisers
ZBH icon

Vanguard Global Advisers’s Zimmer Biomet ZBH Stock Holding History

Vanguard Global Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.3M Sell
444,616
-15,158
-3% -$1.33M 0.02% 466
2026
Q1 		$41.6M Buy
+459,774
New +$42.2M 0.02% 442

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Global Advisers's ZBH Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Zimmer Biomet (ZBH) stake by 3.3% in Q2 2026, selling an estimated $1.33M and leaving 444,616 shares worth $38.3M. The position accounts for 0.02% of the portfolio, ranked #466.

Vanguard Global Advisers first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $41.6M in Q1 2026. 853 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Vanguard Global Advisers held 444,616 shares of Zimmer Biomet worth $38.3M as of Q2 2026.
  • Vanguard Global Advisers sold 15,158 Zimmer Biomet shares in Q2 2026, an estimated $1.33M.
  • Zimmer Biomet made up 0.02% of Vanguard Global Advisers's portfolio in Q2 2026, its #466 holding.
  • Vanguard Global Advisers first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Zimmer Biomet position peaked at $41.6M in Q1 2026.
  • 853 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.